Strides Pharma rises with arm getting USFDA nod for Potassium Chloride Extended Release Tablets

05 Sep 2018 Evaluate

Strides Pharma Science is currently trading at Rs. 487.00, up by 6.95 points or 1.45% from its previous closing of Rs. 480.05 on the BSE.

The scrip opened at Rs. 478.70 and has touched a high and low of Rs. 494.80 and Rs. 476.55 respectively. So far 94056 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1,065.78 on 20-Sep-2017 and a 52 week low of Rs. 334.10 on 08-Jun-2018.

Last one week high and low of the scrip stood at Rs. 512.65 and Rs. 476.55 respectively. The current market cap of the company is Rs. 4397.75 crore.

The promoters holding in the company stood at 31.34%, while Institutions and Non-Institutions held 46.21% and 22.44% respectively.

Strides Pharma Science’s step-down wholly owned subsidiary, Strides Pharma Global, Singapore has received approval for Potassium Chloride Extended Release Tablets USP, 8 mEq (600 mg) and 10 mEq (750 mg) from the United States Food & Drug Administration (USFDA). This is the second Extended Release product approval for Strides and the company has a strong pipeline of products leveraging its capability in the Extended Release delivery technology. Potassium Chloride Extended-Release tablets is a generic version of Klor-Con Extended Release Tablets of Upsher-Smith and Strides is the first Indian generic company to receive this approval.

According to IQVIA MAT data, the US market for Potassium Chloride Extended Release Tablets is approximately $60 million. The product will be manufactured at the company’s facility at Bangalore and marketed by Strides Pharma in the US Market. The company has 78 cumulative ANDA filings with USFDA of which 52 ANDAs have been approved as of date and 26 are pending approval.

Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.

Strides Pharma Scien Share Price

808.95 12.75 (1.60%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×